CoChat

RETRACTED ARTICLE: Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling

Open access
Han, Ihn, Yun, Miyong, Kim, Eun-Ok, Kim, Bonglee, Jung, Min-Hyung, Kim, Sung-Hoon · 2014 · Stem Cell Research & Therapy
Cited by 56

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Introduction: Although mesenchymal stem cells (MSCs) have antitumor potential in hepatocellular carcinoma and breast cancer cells, the antitumor mechanism of human umbilical cord mesenchymal stem cells (hUCMSCs) in prostate cancer cells still remains unclear. Thus, in the present study, we elucidated the antitumor activity of hUCMSCs in PC-3 prostate cancer cells in vitro and in vivo. Methods: hUCMSCs were isolated from Wharton jelly of umbilical cord and characterized via induction of differentiations, osteogenesis, and adipogenesis. Antitumor effects of UCMSCs on tumor growth were evaluated in a co-culture condition with PC-3 prostate cancer cells. PC-3 cells were subcutaneously (sc) injected into the left flank of nude mice, and UCMSCs were sc injected into the right flank of the same mouse. Results: We found that hUCMSCs inhibited the proliferation of PC-3 cells in the co-culture condition. Furthermore, co-culture of hUCMSCs induced the cleavage of caspase 9/3 and PARP, activated c-jun NH2-terminal kinase (JNK), and Bax, and attenuated the phosphorylation of phosphatidylinositol 3-kinase (PI3K)/ AKT, extracellular signal-regulated kinase (ERK), and the expression of survival genes such as Bcl-2, Bcl-xL, Survivin, Mcl-1, and cIAP-1 in PC-3 cells in Western blotting assay. Conversely, we found that treatment of specific JNK inhibitor SP600125 suppressed the cleavages of caspase 9/3 and PARP induced by hUCMSCs in PC-3 cells by Western blotting and immunofluorescence assay. The homing of hUCMSCs to, and TUNEL-positive cells on, the K562 xenograft tumor region were detected in Nu/nu-BALB/c mouse. Conclusions: These results suggest that UCMSCs inhibit tumor growth and have the antitumor potential for PC-3 prostate cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/scrt443This paper is marked retracted.

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 39

  1. Jootar S, Pornprasertsud N, Petvises S, Rerkamnuaychoke B, Disthabanchong S, Pakakasama S, Ungkanont A, Hongeng S: Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Leukoc Res. 2006, 30: 1493-1498. 10.1016/j.leukres.2006.04.013. · DOI
  2. Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D: Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007, 117: 1049-1057. 10.1172/JCI30235. · DOI · Paper page
  3. Lescaudron L, Naveilhan P, Neveu I: The use of stem cells in regenerative medicine for Parkinson’s and Huntington’s diseases. Curr Med Chem. 2012, 19: 6018-6035. 10.2174/092986712804485881. · doi:10.2174/092986712804485881
  4. Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH: Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia. 2009, 57: 13-23. 10.1002/glia.20731. · DOI · Paper page
  5. Anzalone R, Lo Iacono M, Loria T, Di Stefano A, Giannuzzi P, Farina F, La Rocca G: Wharton’s jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev. 2010, 7: 342-363. · DOI
  6. Bersano A, Ballabio E, Lanfranconi S, Boncoraglio GB, Corti S, Locatelli F, Baron P, Bresolin N, Parati E, Candelise L: Clinical studies in stem cells transplantation for stroke: a review. Curr Vasc Pharmacol. 2010, 8: 29-34. 10.2174/157016110790226570. · DOI
  7. Machavariani PT, Dzhalabadze XA, Areshidze TX, Kirvalidze IG: Prospects of stem cells application in patients with ischemic heart disease. Georgian Med News. 2013, 217: 44-49.
  8. Nesselmann C, Ma N, Bieback K, Wagner W, Ho A, Konttinen YT, Zhang H, Hinescu ME, Steinhoff G: Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008, 12: 1795-1810. 10.1111/j.1582-4934.2008.00457.x. · DOI · Paper page
  9. Bartunek J, Behfar A, Vanderheyden M, Wijns W, Terzic A: Mesenchymal stem cells and cardiac repair: principles and practice. J Cardiovasc Transl Res. 2008, 1: 115-119. 10.1007/s12265-008-9021-5. · DOI
  10. Rubart M, Field LJ: Cardiac repair by embryonic stem-derived cells. Handb Exp Pharmacol. 2006, 174: 73-100. · DOI
  11. Puri MC, Nagy A: Concise review: embryonic stem cells versus induced pluripotent stem cells: the game is on. Stem Cells. 2012, 30: 10-14. 10.1002/stem.788. · DOI · Paper page
  12. Fox JM, Chamberlain G, Ashton BA, Middleton J: Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol. 2007, 137: 491-502. 10.1111/j.1365-2141.2007.06610.x. · DOI · Paper page
  13. Hartmann I, Hollweck T, Haffner S, Krebs M, Meiser B, Reichart B, Eissner G: Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J Immunol Methods. 2010, 363: 80-89. 10.1016/j.jim.2010.10.008. · DOI
  14. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006, 91: 1017-1026.
  15. Can A, Karahuseyinoglu S: Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007, 25: 2886-2895. 10.1634/stemcells.2007-0417. · DOI · Paper page
  16. Zeddou M, Briquet A, Relic B, Josse C, Malaise MG, Gothot A, Lechanteur C, Beguin Y: The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int. 2010, 34: 693-701. 10.1042/CBI20090414. · DOI
  17. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC: Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells. 2004, 22: 1330-1337. 10.1634/stemcells.2004-0013. · DOI · Paper page
  18. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR: Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells. 2008, 26: 2865-2874. 10.1634/stemcells.2007-1028. · DOI · Paper page
  19. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasa L, Cappello F, Zummo G, Farina F: Isolation and characterization of Oct-4+/HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2009, 131: 267-282. 10.1007/s00418-008-0519-3. · DOI · Paper page
  20. Chen K, Wang D, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Zhu D, Bayard F, Han ZC: Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol. 2010, 135: 448-458. 10.1016/j.clim.2010.01.015. · DOI · Paper page
  21. Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S: Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 2011, 20: 665-667. · DOI · Paper page
  22. Gondi CS, Gogineni VR, Chetty C, Dasari VR, Gorantla B, Gujrati M, Dinh DH, Rao JS: Induction of apoptosis in glioma cells requires cell-to-cell contact with human umbilical cord blood stem cells. Int J Oncol. 2010, 36: 1165-1173.
  23. Chao KC, Yang HT, Chen MW: Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization. J Cell Mol Med. 2011, 16: 1803-1815. · DOI
  24. Sanguinetti A, Bistoni G, Avenia N: Stem cells and breast cancer, where we are? A concise review of literature. G Chir. 2011, 32: 438-446.
  25. Tian X, Fu R, Deng L: Method and conditions of isolation and proliferation of multipotent mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007, 21: 81-85.
  26. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A: Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007, 25: 319-331. 10.1634/stemcells.2006-0286. · DOI · Paper page
  27. Han I, Jeong SJ, Lee HJ, Koh W, Lee EO, Kim HS, Lee SJ, Chen CY, Jung MH, Kim SH: Proteomic analysis of mesenchymal stem-like cells derived from ovarian teratoma: potential role of glutathione S-transferase M2 in ovarian teratoma. Proteomics. 2011, 11: 352-360. 10.1002/pmic.201000475. · DOI
  28. Carlin R, Davis D, Weiss M, Schultz B, Troyer D: Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol. 2006, 4: 8-10.1186/1477-7827-4-8. · DOI · Paper page
  29. Molloy AP, Martin FT, Dwyer RM, Griffin TP, Murphy M, Barry FP, O’Brien T, Kerin MJ: Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer. 2009, 124: 326-332. 10.1002/ijc.23939. · DOI · Paper page
  30. Honsawek S, Dhitiseith D, Phupong V: Effects of demineralized bone matrix on proliferation and osteogenic differentiation of mesenchymal stem cells from human umbilical cord. J Med Assoc Thai. 2006, 89: S189-S195.
  31. Hollweck T, Marschmann M, Hartmann I, Akra B, Meiser B, Reichart B, Eblenkamp M, Wintermantel E, Eissner G: Comparative analysis of adherence, viability, proliferation and morphology of umbilical cord tissue-derived mesenchymal stem cells seeded on different titanium-coated expanded polytetrafluoroethylene scaffolds. Biomed Mater. 2010, 5: 065004-10.1088/1748-6041/5/6/065004. · doi:10.1088/1748-6041/5/6/065004
  32. Hu L, Hu J, Zhao J, Liu J, Ouyang W, Yang C, Gong N, Du L, Khanal A, Chen L: Side-by-side comparison of the biological characteristics of human umbilical cord and adipose tissue-derived mesenchymal stem cells. Biomed Res Int. 2013, 2013: 438243-
  33. Akimoto K, Kimura K, Nagano M, Takano S, To’a Salazar G, Yamashita T, Ohneda O: Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev. 2012, 22: 1370-1386. · DOI · Paper page
  34. Strauer BE, Schannwell CM, Brehm M: Therapeutic potentials of stem cells in cardiac diseases. Minerva Cardioangiol. 2009, 57: 249-267.
  35. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK: Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012, 45: 487-498. 10.1111/j.1365-2184.2012.00845.x. · DOI · Paper page
  36. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007, 35: 495-516. 10.1080/01926230701320337. · DOI · Paper page
  37. Chen F: JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012, 72: 379-386. 10.1158/0008-5472.CAN-11-1982. · DOI · Paper page
  38. Aikin R, Maysinger D, Rosenberg L: Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology. 2004, 145: 4522-4531. 10.1210/en.2004-0488. · DOI
  39. Liang L, Dong C, Chen X, Fang Z, Xu J, Liu M, Zhang X, Gu DS, Wang D, Du W, Zhu D, Han ZC: Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant. 2011, 20: 1395-1408. 10.3727/096368910X557245. · DOI

Cited by

Metadata

Authors
Han, I., Yun, M., Kim, E.-O., Kim, B., Jung, M.-H., & Kim, S.-H.
Venue
Stem Cell Research & Therapy
Published
2014-04-16
Volume
5
Issue
2
Pages
354-354
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2170380796
Cited by
56
References
5
FWCI
4.05
Type
journal article
Language
en
Status
Retracted
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.